Dr Andrew Lucke

Senior Research Officer

Institute for Molecular Bioscience
a.lucke@imb.uq.edu.au
+61 7 334 62988

Overview

Qualifications

  • Doctor of Philosophy, Griffith University
  • BSc(Hons), Griffith University

Publications

  • Sheng, Yong Hua, Giri, Rabina, Davies, Julie, Schreiber, Veronika, Alabbas, Saleh, Movva, Ramya, He, Yaowu, Wu, Andy, Hooper, John, McWhinney, Brett, Oancea, Iulia, Kijanka, Gregor, Hasnain, Sumaira, Lucke, Andrew J., Fairlie, David P., McGuckin, Michael A., Florin, Timothy H. and Begun, Jakob (2020). A nucleotide analog prevents colitis associated cancer via Β-catenin independently of inflammation and autophagy. Cellular and Molecular Gastroenterology and Hepatology doi:10.1016/j.jcmgh.2020.05.012

  • Tng, Jiahui, Lim, Junxian, Wu, Kai-Chen, Lucke, Andrew J., Xu, Weijun, Reid, Robert C. and Fairlie, David P. (2020). Achiral derivatives of hydroxamate AR-42 potently inhibit class I HDAC enzymes and cancer cell proliferation. Journal of Medicinal Chemistry, 63 (11) acs.jmedchem.0c00230, 5956-5971. doi:10.1021/acs.jmedchem.0c00230

  • Nielsen, Daniel S., Shepherd, Nicholas E., Xu, Weijun, Lucke, Andrew J., Stoermer, Martin J. and Fairlie, David P. (2019). Supplementary Data tables for: Orally absorbed cyclic peptides. The University of Queensland. (Dataset) doi: 10.14264/uql.2019.213

View all Publications

Publications

Book Chapter

  • Lucke, Andrew, Stirling, Charles J. M. and BÖhmer, Volker (2002). Mono- and multi-layers. Calixarenes 2001. (pp. 612-626) edited by Zouhair Asfari, Volker Böhmer, Jack Harrowfield and Jacques Vicens.Dordrecht, Netherlands : Kluwer Academic Publishers. doi:10.1007/0-306-47522-7_33

  • Lucke, Andrew J. and Stirling, Charles J. M. (2000). Calixarenes in thin film supramolecular materials. Calixarenes in Action. (pp. 172-202) edited by Luigi Mandolini and Rocco Ungaro.London, United Kingdom: Imperial College Press. doi:10.1142/9781848160354_0008

Journal Article

Conference Publication

  • Plisson, Fabien , Lucke, Andrew, Nielsen, Daniel , Stoermer, Martin J. and Fairlie, David (2014). Mining physicochemical features that contribute to oral bioavailability in peptide middle space. European QSAR Symposium, St Petersburg, Russia, September 2014.

  • Fairlie, David P., Stoermer, Martin, Lucke, Andrew, Lohman, Rink-Jan, Liu, Ligong and Ruiz-Gomez, Gloria (2011). Towards orally bioavailable peptides and peptidomimetics. 241st National Meeting and Exposition of the American-Chemical-Society (ACS), Anaheim, CA, United States, 27-31 March 2011. Washington, DC, United States :American Chemical Society.

  • Andrews, Kathy T., Tran, Thanh N., Lucke, Andrew, Kahnberg, Pia, Lee, G. T., Skinner-Adams, Tina, Gardiner, Donald L. and Fairlie, David P. (2007). Plasmodium falciparum histone deacetylases: Enzymes involved in gene regulation as new antimalarial drug targets. 56th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene, Philadelphia, PA United States, 04-08 November 2007. Deerfield, IL United States :American Society of Tropical Medicine and Hygiene.

Other Outputs

  • Nielsen, Daniel S., Shepherd, Nicholas E., Xu, Weijun, Lucke, Andrew J., Stoermer, Martin J. and Fairlie, David P. (2019). Supplementary Data tables for: Orally absorbed cyclic peptides. The University of Queensland. (Dataset) doi: 10.14264/uql.2019.213